Proportion of EGFR and KRAS mutations found according to women (upper table) and men (lower table)
| Total | EGFR positive (%) | KRAS positive (%) | |||
|---|---|---|---|---|---|
| Total number of women | 200 | 17 | 8.5 | 42 | 21.0 |
| Adenocarcinoma | 116 | 16 | 13.8 | 31 | 26.7 |
| Squamous cell carcinoma | 47 | 0 | 0.0 | 2 | 4.3 |
| Large cell carcinoma | 28 | 1 | 3.6 | 7 | 25.0 |
| Sarcomatoid carcinoma | 0 | 0 | 0.0 | 0 | 0.0 |
| Adenosquamous carcinoma | 0 | 0 | 0.0 | 0 | 0.0 |
| NOS (non other specified) | 9 | 0 | 0.0 | 2 | 22.2 |
| Total number of men | 352 | 10 | 2.8 | 43 | 12.2 |
| Adenocarcinoma | 138 | 6 | 4.3 | 36 | 26.1 |
| Squamous cell carcinoma | 139 | 2 | 1.4 | 3 | 2.2 |
| Large cell carcinoma | 51 | 1 | 2.0 | 4 | 7.8 |
| Sarcomatoides Karzinom | 7 | 0 | 0.0 | 0 | 0.0 |
| Adenosquamous carcinoma | 5 | 1 | 20.0 | 0 | 0.0 |
| NOS (non other specified) | 12 | 0 | 0.0 | 0 | 0.0 |